全球临床试验用品市场 – 行业趋势及 2031 年预测

临床试验用品市场分析和规模

在临床试验用品市场，区块链技术的整合确保了供应链管理的透明性和安全性，而人工智能驱动的预测则优化了库存管理。RFID标签增强了实时跟踪，减少了错误并提高了效率。这些进步改变了行业，简化了流程并确保了法规遵从性。                                

Data Bridge Market Research 分析，全球临床试验用品市场在 2023 年为 35.3 亿美元，预计到 2031 年将达到 67.4 亿美元，预计在 2024 年至 2031 年的预测期内复合年增长率为 8.4%。这表明市场价值。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Clinical trial supplies refer to the materials and equipment essential for conducting medical research on new treatments or interventions. These supplies encompass medications, placebos, medical devices, and ancillary items required for the trial's execution. Ensuring timely and accurate provision of these resources is critical for the integrity and success of the trial.            

Global Clinical Trial Supplies Market Dynamics

Drivers

• Growing Biopharmaceutical Industry Create Demand

As the biopharmaceutical sector expands, especially in biologics and modified medicine, there is a surge in demand for clinical trial supplies to facilitate research and development efforts. This heightened demand underscores the crucial role of efficient supply chains in enabling the advancement of innovative therapies and improving patient outcomes in healthcare.

• Rising Prevalence of Chronic Diseases Create Demand for Clinical Trial

The surge in chronic diseases such as cancer, cardiovascular issues, and autoimmune disorders intensifies the demand for clinical trials to pioneer new treatments. This heightened need for innovative therapies directly fuels the demand for clinical trial supplies, underlining their pivotal role in advancing medical research and addressing evolving healthcare challenges.

Opportunities

• Focus on Patient-Centric Trials for Improved Trial Experiences

Clinical trials increasingly prioritize patient needs, employing customized supply strategies for convenience, compliance, and retention. Direct-to-patient delivery and mobile health tech play vital roles, enhancing accessibility and engagement. Patient-centric approaches drive improved trial experiences, fostering greater participation and data accuracy for enhanced medical research outcomes.

• Advancements in Technology to Enhance the Efficiency of Clinical Trial Supply Operations

Technological advancements in supply chain management, packaging, and temperature-controlled logistics enhance the efficiency, accuracy, and safety of clinical trial supply operations. This drives adoption among pharmaceutical companies and contract research organizations (CROs), facilitating streamlined processes and ensuring compliance with regulatory requirements. 

Restraints/Challenges

• Growing Concern of Data Security and Privacy

The growing concern over data security and privacy is particularly pertinent in the global clinical trial supplies market. With the sensitive nature of patient data and the criticality of maintaining confidentiality, ensuring robust security measures is imperative. Breaches in data security not only jeopardize patient privacy but also undermine the integrity and reliability of clinical trial results.

• Growing Complexity of Trial Designs

The rise of complex trial designs such as adaptive or basket trials complicates demand forecasting and inventory management in the clinical trial supplies market. This complexity increases the risk of overstocking or shortages, leading to inefficient resource allocation and potentially higher charges, thus hampering market efficiency and profitability.

This global clinical trial supplies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global clinical trial supplies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Thermo Fisher Scientific partnered with Medidata to enhance patient enrollment speed and clinical site selection, optimizing clinical trial planning and execution. This collaboration leverages datasets from 26,000 trials and 8 million patients worldwide, contributing to the evolving clinical trial supplies market
• In 2021, Thermo Fisher Scientific acquired PPD, Inc., a major clinical research services provider, for $17.4 billion, assuming PPD's net debt of approximately $3.0 billion. This acquisition significantly impacted the clinical trial supplies market, broadening Thermo Fisher's portfolio and global reach
• In 2020, Catalent, Inc. launched FlexDirect clinical supply services, offering pharmacy-to-patient and site-to-patient distribution alongside standard clinical supplies delivery. This hybrid approach caters to diverse sponsor needs, driving growth in the clinical trial supplies market through enhanced service customization and efficiency
• In 2020, Almac Clinical Services launched Tempod 1000, aimed at streamlining temperature logging processes in clinical settings. This digital solution improves patient safety and aligns with best practices, contributing to the evolution of digital technologies within the clinical trial supplies market

Global Clinical Trial Supplies Market Scope

The global clinical trial supplies market is segmented on the basis services, clinical phase, therapeutic uses and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Services

• Storage
• Manufacturing
• Packaging and Labelling
• Distribution

 Clinical Phase

• Phase III
• Phase II
• Phase IV
• Phase I

 Therapeutic Uses

• Oncology
• Cardiovascular Diseases
• Dermatology
• Metabolic Disorders
• Infectious Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Blood Disorders
• Others

 End User

• Contract Research Organizations
• Pharmaceutical
• Biotechnology Companies

Global Clinical Trial Supplies Market Regional Analysis/Insights

The global clinical trial supplies market is analysed and market size insights and trends are provided by country, services, clinical phase, therapeutic uses and end user as referenced above.

The countries covered in the global clinical trial supplies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the clinical trial supplies market, holding significant market share and revenue. Its continued dominance is attributed to major key players and a well-developed healthcare infrastructure, ensuring sustained growth throughout the forecast period.

Asia-Pacific region is expected to exhibit the highest growth rate in the clinical trial supplies market, attributed to the expanding patient pool, escalating investments in healthcare, and robust government backing. This surge underscores the region's pivotal role in advancing clinical research and pharmaceutical development.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

全球临床试验用品市场还为您提供每个国家/地区资本设备医疗保健支出增长、全球临床试验用品市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对全球临床试验用品市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和全球临床试验用品市场份额分析

全球临床试验用品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球临床试验用品市场的关注有关。

全球临床试验用品市场的一些主要参与者包括：

• Movianto（美国）
• Sharp Services, LLC（美国）
• Thermo Fisher Scientific Inc.（美国）
• Catalent, Inc（美国）
•  PCI 制药服务（美国）
•  Almac 集团 (英国)
•  PAREXEL 国际公司（美国）
•  Bionic Emas（英国）
•  Alium Medical Limited（英国）
• Myonex (英国)
• Clinigen Limited（英国）
•  Ancillare, LP（美国）
•  SIRO Clinpharm Private Limited（印度）
• Clinigen 临床用品管理（美国）
• Biocair（英国）

SKU-23982